Document Type
Article
Publication Date
10-17-2024
Abstract
Shrimp allergy, the most common food allergy in the United States, affects up to 2% of the population. Its etiology is multi-factorial with the combination of genetic predisposition and environmental exposures. This review summarizes the latest diagnosis and management strategies for shrimp allergy. Currently, the double-blind, placebo-controlled food challenge is the gold standard for diagnosis. Moreover, mainstream and experimental management strategies include food allergen avoidance, the FDA-approved omalizumab, and oral immunotherapy. Herein, we emphasize the urgent need to develop more effective diagnostic tools and therapies for shrimp allergy.
Recommended Citation
Su, B. B., Blackmon, W., Xu, C., Holt, C., Boateng, N., Wang, D., ... & Davis, C. M. (2024). Diagnosis and management of shrimp allergy. Frontiers in Allergy, 5, 1456999. https://doi.org/10.3389/falgy.2024.1456999
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publication Title
Frontiers in Allergy
DOI
https://doi.org/10.3389/falgy.2024.1456999
Comments
© 2024 Su, Blackmon, Xu, Holt, Boateng, Wang, Szafron, Anagnostou, Anvari and Davis. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.